Clinical Trial: A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

Clinical Trial: A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

Sponsor and Collaborators

University of Pittsburgh
National Cancer Institute (NCI)

Contact

Contact: Athanassios Argiris, MD
(412) 623-4083
argirisae@upmc.edu

Contact: Rita Johnson, RN
(412) 547-5871
johnsonr1@upmc.edu

Principal Investigator
Athanassios Argiris, MD ECOG

ClinicalTrials.gov Identifier
NCT00409565
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs